Four pharma companies stand accused in the UK of colluding to artificially inflate the price of prescription-only, anti-nausea and dizziness drug prochlorperazine, costing the NHS millions of pounds and breaking competition law.
Shire has teamed up with Microsoft and EURORDIS-Rare Diseases Europe in a strategic alliance aiming to tackle the diagnostic challenge for patients living with a rare disease.